Performance characteristics and operational feasibility assessment of a CRISPR based tata MD CHECK diagnostic test for SARS-CoV-2 (COVID-19).

Shubhada ShenaiGita NatarajMinal JinwalAkhil S Thekke PurakkalRajashree SenNayana IngoleTrupti MathureSanjay SarinSarabjit S Chadha

Published in: PloS one (2023)

The evaluated version-Tata MD CHECK SARS-CoV-2 kit 1.0 of TMC-CRISPR test cannot be considered as an alternative to the RT-PCR. There is a definite scope for improvement in this assay.

Keyphrases

sars cov
genome editing
crispr cas
genome wide
respiratory syndrome coronavirus
molecular dynamics
high throughput
coronavirus disease
dna methylation
gene expression
single cell